 | • レポートコード：GIR-23F3927 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Sheep and Goat Pox Vaccines Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の羊痘及び山羊痘ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 羊痘及び山羊痘ワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・生ワクチン、不活化ワクチン アプリケーション別セグメントは次のように区分されます。 ・羊、山羊 世界の羊痘及び山羊痘ワクチン市場の主要なマーケットプレーヤーは以下のとおりです。 ・Agrovet、Biopharma、Dollvet、FGBI - Federal Centre for Animal Health、Hester Biosciences Limited、Indian Immunologicals Limited、Institut Pasteur d'Algerie、Intervac (PVT) Ltd.、JOVAC、Tiankang Biopharmacuetical、Vetal Company、Veterinary Research Institute 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 羊痘及び山羊痘ワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：生ワクチン、不活化ワクチン - アプリケーション別分析（2017年vs2021年vs2028年）：羊、山羊 - 世界の羊痘及び山羊痘ワクチン市場規模・予測 - 世界の羊痘及び山羊痘ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Agrovet、Biopharma、Dollvet、FGBI - Federal Centre for Animal Health、Hester Biosciences Limited、Indian Immunologicals Limited、Institut Pasteur d'Algerie、Intervac (PVT) Ltd.、JOVAC、Tiankang Biopharmacuetical、Vetal Company、Veterinary Research Institute ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：生ワクチン、不活化ワクチン ・アプリケーション別分析2017年-2028年：羊、山羊 ・羊痘及び山羊痘ワクチンの北米市場分析 - 羊痘及び山羊痘ワクチンの北米市場：タイプ別市場規模2017年-2028年 - 羊痘及び山羊痘ワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・羊痘及び山羊痘ワクチンのヨーロッパ市場分析 - ：羊痘及び山羊痘ワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：羊痘及び山羊痘ワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・羊痘及び山羊痘ワクチンのアジア太平洋市場分析 - 羊痘及び山羊痘ワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 羊痘及び山羊痘ワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・羊痘及び山羊痘ワクチンの南米市場分析 - 羊痘及び山羊痘ワクチンの南米市場：タイプ別市場規模2017年-2028年 - 羊痘及び山羊痘ワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・羊痘及び山羊痘ワクチンの中東・アフリカ市場分析 - 羊痘及び山羊痘ワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 羊痘及び山羊痘ワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Sheep and Goat Pox Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Sheep and Goat Pox Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Sheep accounting for % of the Sheep and Goat Pox Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Live Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Sheep and Goat Pox Vaccines include Agrovet, Biopharma, Dollvet, FGBI – Federal Centre for Animal Health, and Hester Biosciences Limited, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Sheep and Goat Pox Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Live Vaccines
Killed Vaccines
Market segment by Application can be divided into
Sheep
Goat
The key market players for global Sheep and Goat Pox Vaccines market are listed below:
Agrovet
Biopharma
Dollvet
FGBI – Federal Centre for Animal Health
Hester Biosciences Limited
Indian Immunologicals Limited
Institut Pasteur d’Algerie
Intervac (PVT) Ltd.
JOVAC
Tiankang Biopharmacuetical
Vetal Company
Veterinary Research Institute
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sheep and Goat Pox Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sheep and Goat Pox Vaccines, with price, sales, revenue and global market share of Sheep and Goat Pox Vaccines from 2019 to 2022.
Chapter 3, the Sheep and Goat Pox Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sheep and Goat Pox Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Sheep and Goat Pox Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sheep and Goat Pox Vaccines.
Chapter 13, 14, and 15, to describe Sheep and Goat Pox Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Sheep and Goat Pox Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sheep and Goat Pox Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Sheep and Goat Pox Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Sheep
1.3.3 Goat
1.4 Global Sheep and Goat Pox Vaccines Market Size & Forecast
1.4.1 Global Sheep and Goat Pox Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Sheep and Goat Pox Vaccines Sales in Volume (2017-2028)
1.4.3 Global Sheep and Goat Pox Vaccines Price (2017-2028)
1.5 Global Sheep and Goat Pox Vaccines Production Capacity Analysis
1.5.1 Global Sheep and Goat Pox Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Sheep and Goat Pox Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sheep and Goat Pox Vaccines Market Drivers
1.6.2 Sheep and Goat Pox Vaccines Market Restraints
1.6.3 Sheep and Goat Pox Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Agrovet
2.1.1 Agrovet Details
2.1.2 Agrovet Major Business
2.1.3 Agrovet Sheep and Goat Pox Vaccines Product and Services
2.1.4 Agrovet Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Biopharma
2.2.1 Biopharma Details
2.2.2 Biopharma Major Business
2.2.3 Biopharma Sheep and Goat Pox Vaccines Product and Services
2.2.4 Biopharma Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Dollvet
2.3.1 Dollvet Details
2.3.2 Dollvet Major Business
2.3.3 Dollvet Sheep and Goat Pox Vaccines Product and Services
2.3.4 Dollvet Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 FGBI – Federal Centre for Animal Health
2.4.1 FGBI – Federal Centre for Animal Health Details
2.4.2 FGBI – Federal Centre for Animal Health Major Business
2.4.3 FGBI – Federal Centre for Animal Health Sheep and Goat Pox Vaccines Product and Services
2.4.4 FGBI – Federal Centre for Animal Health Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hester Biosciences Limited
2.5.1 Hester Biosciences Limited Details
2.5.2 Hester Biosciences Limited Major Business
2.5.3 Hester Biosciences Limited Sheep and Goat Pox Vaccines Product and Services
2.5.4 Hester Biosciences Limited Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Indian Immunologicals Limited
2.6.1 Indian Immunologicals Limited Details
2.6.2 Indian Immunologicals Limited Major Business
2.6.3 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Product and Services
2.6.4 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Institut Pasteur d’Algerie
2.7.1 Institut Pasteur d’Algerie Details
2.7.2 Institut Pasteur d’Algerie Major Business
2.7.3 Institut Pasteur d’Algerie Sheep and Goat Pox Vaccines Product and Services
2.7.4 Institut Pasteur d’Algerie Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Intervac (PVT) Ltd.
2.8.1 Intervac (PVT) Ltd. Details
2.8.2 Intervac (PVT) Ltd. Major Business
2.8.3 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Product and Services
2.8.4 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 JOVAC
2.9.1 JOVAC Details
2.9.2 JOVAC Major Business
2.9.3 JOVAC Sheep and Goat Pox Vaccines Product and Services
2.9.4 JOVAC Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Tiankang Biopharmacuetical
2.10.1 Tiankang Biopharmacuetical Details
2.10.2 Tiankang Biopharmacuetical Major Business
2.10.3 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Product and Services
2.10.4 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Vetal Company
2.11.1 Vetal Company Details
2.11.2 Vetal Company Major Business
2.11.3 Vetal Company Sheep and Goat Pox Vaccines Product and Services
2.11.4 Vetal Company Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Veterinary Research Institute
2.12.1 Veterinary Research Institute Details
2.12.2 Veterinary Research Institute Major Business
2.12.3 Veterinary Research Institute Sheep and Goat Pox Vaccines Product and Services
2.12.4 Veterinary Research Institute Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Sheep and Goat Pox Vaccines Breakdown Data by Manufacturer
3.1 Global Sheep and Goat Pox Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Sheep and Goat Pox Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Sheep and Goat Pox Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Sheep and Goat Pox Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Sheep and Goat Pox Vaccines Manufacturer Market Share in 2021
3.5 Global Sheep and Goat Pox Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Sheep and Goat Pox Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sheep and Goat Pox Vaccines Market Size by Region
4.1.1 Global Sheep and Goat Pox Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Sheep and Goat Pox Vaccines Revenue by Region (2017-2028)
4.2 North America Sheep and Goat Pox Vaccines Revenue (2017-2028)
4.3 Europe Sheep and Goat Pox Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Sheep and Goat Pox Vaccines Revenue (2017-2028)
4.5 South America Sheep and Goat Pox Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Sheep and Goat Pox Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Sheep and Goat Pox Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Sheep and Goat Pox Vaccines Revenue by Type (2017-2028)
5.3 Global Sheep and Goat Pox Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Sheep and Goat Pox Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Sheep and Goat Pox Vaccines Revenue by Application (2017-2028)
6.3 Global Sheep and Goat Pox Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Sheep and Goat Pox Vaccines Sales by Type (2017-2028)
7.2 North America Sheep and Goat Pox Vaccines Sales by Application (2017-2028)
7.3 North America Sheep and Goat Pox Vaccines Market Size by Country
7.3.1 North America Sheep and Goat Pox Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Sheep and Goat Pox Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Sheep and Goat Pox Vaccines Sales by Type (2017-2028)
8.2 Europe Sheep and Goat Pox Vaccines Sales by Application (2017-2028)
8.3 Europe Sheep and Goat Pox Vaccines Market Size by Country
8.3.1 Europe Sheep and Goat Pox Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Sheep and Goat Pox Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Sheep and Goat Pox Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Sheep and Goat Pox Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Sheep and Goat Pox Vaccines Market Size by Region
9.3.1 Asia-Pacific Sheep and Goat Pox Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Sheep and Goat Pox Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Sheep and Goat Pox Vaccines Sales by Type (2017-2028)
10.2 South America Sheep and Goat Pox Vaccines Sales by Application (2017-2028)
10.3 South America Sheep and Goat Pox Vaccines Market Size by Country
10.3.1 South America Sheep and Goat Pox Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Sheep and Goat Pox Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sheep and Goat Pox Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Sheep and Goat Pox Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Sheep and Goat Pox Vaccines Market Size by Country
11.3.1 Middle East & Africa Sheep and Goat Pox Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Sheep and Goat Pox Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Sheep and Goat Pox Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Sheep and Goat Pox Vaccines
12.3 Sheep and Goat Pox Vaccines Production Process
12.4 Sheep and Goat Pox Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Sheep and Goat Pox Vaccines Typical Distributors
13.3 Sheep and Goat Pox Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Sheep and Goat Pox Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Sheep and Goat Pox Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Agrovet Basic Information, Manufacturing Base and Competitors
Table 4. Agrovet Major Business
Table 5. Agrovet Sheep and Goat Pox Vaccines Product and Services
Table 6. Agrovet Sheep and Goat Pox Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Biopharma Basic Information, Manufacturing Base and Competitors
Table 8. Biopharma Major Business
Table 9. Biopharma Sheep and Goat Pox Vaccines Product and Services
Table 10. Biopharma Sheep and Goat Pox Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Dollvet Basic Information, Manufacturing Base and Competitors
Table 12. Dollvet Major Business
Table 13. Dollvet Sheep and Goat Pox Vaccines Product and Services
Table 14. Dollvet Sheep and Goat Pox Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. FGBI - Federal Centre for Animal Health Basic Information, Manufacturing Base and Competitors
Table 16. FGBI - Federal Centre for Animal Health Major Business
Table 17. FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Product and Services
Table 18. FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Hester Biosciences Limited Basic Information, Manufacturing Base and Competitors
Table 20. Hester Biosciences Limited Major Business
Table 21. Hester Biosciences Limited Sheep and Goat Pox Vaccines Product and Services
Table 22. Hester Biosciences Limited Sheep and Goat Pox Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Indian Immunologicals Limited Basic Information, Manufacturing Base and Competitors
Table 24. Indian Immunologicals Limited Major Business
Table 25. Indian Immunologicals Limited Sheep and Goat Pox Vaccines Product and Services
Table 26. Indian Immunologicals Limited Sheep and Goat Pox Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Institut Pasteur d'Algerie Basic Information, Manufacturing Base and Competitors
Table 28. Institut Pasteur d'Algerie Major Business
Table 29. Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Product and Services
Table 30. Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Intervac (PVT) Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. Intervac (PVT) Ltd. Major Business
Table 33. Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Product and Services
Table 34. Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. JOVAC Basic Information, Manufacturing Base and Competitors
Table 36. JOVAC Major Business
Table 37. JOVAC Sheep and Goat Pox Vaccines Product and Services
Table 38. JOVAC Sheep and Goat Pox Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Tiankang Biopharmacuetical Basic Information, Manufacturing Base and Competitors
Table 40. Tiankang Biopharmacuetical Major Business
Table 41. Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Product and Services
Table 42. Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Vetal Company Basic Information, Manufacturing Base and Competitors
Table 44. Vetal Company Major Business
Table 45. Vetal Company Sheep and Goat Pox Vaccines Product and Services
Table 46. Vetal Company Sheep and Goat Pox Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 48. Veterinary Research Institute Major Business
Table 49. Veterinary Research Institute Sheep and Goat Pox Vaccines Product and Services
Table 50. Veterinary Research Institute Sheep and Goat Pox Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Sheep and Goat Pox Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Sheep and Goat Pox Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Sheep and Goat Pox Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Sheep and Goat Pox Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Sheep and Goat Pox Vaccines Production Site of Key Manufacturer
Table 56. Sheep and Goat Pox Vaccines New Entrant and Capacity Expansion Plans
Table 57. Sheep and Goat Pox Vaccines Mergers & Acquisitions in the Past Five Years
Table 58. Global Sheep and Goat Pox Vaccines Sales by Region (2017-2022) & (K Units)
Table 59. Global Sheep and Goat Pox Vaccines Sales by Region (2023-2028) & (K Units)
Table 60. Global Sheep and Goat Pox Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Sheep and Goat Pox Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Sheep and Goat Pox Vaccines Sales by Type (2017-2022) & (K Units)
Table 63. Global Sheep and Goat Pox Vaccines Sales by Type (2023-2028) & (K Units)
Table 64. Global Sheep and Goat Pox Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Sheep and Goat Pox Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Sheep and Goat Pox Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 67. Global Sheep and Goat Pox Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 68. Global Sheep and Goat Pox Vaccines Sales by Application (2017-2022) & (K Units)
Table 69. Global Sheep and Goat Pox Vaccines Sales by Application (2023-2028) & (K Units)
Table 70. Global Sheep and Goat Pox Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Sheep and Goat Pox Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Sheep and Goat Pox Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 73. Global Sheep and Goat Pox Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 74. North America Sheep and Goat Pox Vaccines Sales by Country (2017-2022) & (K Units)
Table 75. North America Sheep and Goat Pox Vaccines Sales by Country (2023-2028) & (K Units)
Table 76. North America Sheep and Goat Pox Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Sheep and Goat Pox Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Sheep and Goat Pox Vaccines Sales by Type (2017-2022) & (K Units)
Table 79. North America Sheep and Goat Pox Vaccines Sales by Type (2023-2028) & (K Units)
Table 80. North America Sheep and Goat Pox Vaccines Sales by Application (2017-2022) & (K Units)
Table 81. North America Sheep and Goat Pox Vaccines Sales by Application (2023-2028) & (K Units)
Table 82. Europe Sheep and Goat Pox Vaccines Sales by Country (2017-2022) & (K Units)
Table 83. Europe Sheep and Goat Pox Vaccines Sales by Country (2023-2028) & (K Units)
Table 84. Europe Sheep and Goat Pox Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Sheep and Goat Pox Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Sheep and Goat Pox Vaccines Sales by Type (2017-2022) & (K Units)
Table 87. Europe Sheep and Goat Pox Vaccines Sales by Type (2023-2028) & (K Units)
Table 88. Europe Sheep and Goat Pox Vaccines Sales by Application (2017-2022) & (K Units)
Table 89. Europe Sheep and Goat Pox Vaccines Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Sheep and Goat Pox Vaccines Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Sheep and Goat Pox Vaccines Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Sheep and Goat Pox Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Sheep and Goat Pox Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Sheep and Goat Pox Vaccines Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Sheep and Goat Pox Vaccines Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Sheep and Goat Pox Vaccines Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Sheep and Goat Pox Vaccines Sales by Application (2023-2028) & (K Units)
Table 98. South America Sheep and Goat Pox Vaccines Sales by Country (2017-2022) & (K Units)
Table 99. South America Sheep and Goat Pox Vaccines Sales by Country (2023-2028) & (K Units)
Table 100. South America Sheep and Goat Pox Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Sheep and Goat Pox Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Sheep and Goat Pox Vaccines Sales by Type (2017-2022) & (K Units)
Table 103. South America Sheep and Goat Pox Vaccines Sales by Type (2023-2028) & (K Units)
Table 104. South America Sheep and Goat Pox Vaccines Sales by Application (2017-2022) & (K Units)
Table 105. South America Sheep and Goat Pox Vaccines Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Sheep and Goat Pox Vaccines Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Sheep and Goat Pox Vaccines Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Sheep and Goat Pox Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Sheep and Goat Pox Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Sheep and Goat Pox Vaccines Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Sheep and Goat Pox Vaccines Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Sheep and Goat Pox Vaccines Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Sheep and Goat Pox Vaccines Sales by Application (2023-2028) & (K Units)
Table 114. Sheep and Goat Pox Vaccines Raw Material
Table 115. Key Manufacturers of Sheep and Goat Pox Vaccines Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Sheep and Goat Pox Vaccines Typical Distributors
Table 119. Sheep and Goat Pox Vaccines Typical Customers
List of Figures
Figure 1. Sheep and Goat Pox Vaccines Picture
Figure 2. Global Sheep and Goat Pox Vaccines Revenue Market Share by Type in 2021
Figure 3. Live Vaccines
Figure 4. Killed Vaccines
Figure 5. Global Sheep and Goat Pox Vaccines Revenue Market Share by Application in 2021
Figure 6. Sheep
Figure 7. Goat
Figure 8. Global Sheep and Goat Pox Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Sheep and Goat Pox Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Sheep and Goat Pox Vaccines Sales (2017-2028) & (K Units)
Figure 11. Global Sheep and Goat Pox Vaccines Price (2017-2028) & (USD/Unit)
Figure 12. Global Sheep and Goat Pox Vaccines Production Capacity (2017-2028) & (K Units)
Figure 13. Global Sheep and Goat Pox Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Sheep and Goat Pox Vaccines Market Drivers
Figure 15. Sheep and Goat Pox Vaccines Market Restraints
Figure 16. Sheep and Goat Pox Vaccines Market Trends
Figure 17. Global Sheep and Goat Pox Vaccines Sales Market Share by Manufacturer in 2021
Figure 18. Global Sheep and Goat Pox Vaccines Revenue Market Share by Manufacturer in 2021
Figure 19. Sheep and Goat Pox Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Sheep and Goat Pox Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Sheep and Goat Pox Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Sheep and Goat Pox Vaccines Sales Market Share by Region (2017-2028)
Figure 23. Global Sheep and Goat Pox Vaccines Revenue Market Share by Region (2017-2028)
Figure 24. North America Sheep and Goat Pox Vaccines Revenue (2017-2028) & (USD Million)
Figure 25. Europe Sheep and Goat Pox Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Sheep and Goat Pox Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. South America Sheep and Goat Pox Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Sheep and Goat Pox Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Global Sheep and Goat Pox Vaccines Sales Market Share by Type (2017-2028)
Figure 30. Global Sheep and Goat Pox Vaccines Revenue Market Share by Type (2017-2028)
Figure 31. Global Sheep and Goat Pox Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Sheep and Goat Pox Vaccines Sales Market Share by Application (2017-2028)
Figure 33. Global Sheep and Goat Pox Vaccines Revenue Market Share by Application (2017-2028)
Figure 34. Global Sheep and Goat Pox Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Sheep and Goat Pox Vaccines Sales Market Share by Type (2017-2028)
Figure 36. North America Sheep and Goat Pox Vaccines Sales Market Share by Application (2017-2028)
Figure 37. North America Sheep and Goat Pox Vaccines Sales Market Share by Country (2017-2028)
Figure 38. North America Sheep and Goat Pox Vaccines Revenue Market Share by Country (2017-2028)
Figure 39. United States Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Sheep and Goat Pox Vaccines Sales Market Share by Type (2017-2028)
Figure 43. Europe Sheep and Goat Pox Vaccines Sales Market Share by Application (2017-2028)
Figure 44. Europe Sheep and Goat Pox Vaccines Sales Market Share by Country (2017-2028)
Figure 45. Europe Sheep and Goat Pox Vaccines Revenue Market Share by Country (2017-2028)
Figure 46. Germany Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Sheep and Goat Pox Vaccines Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Sheep and Goat Pox Vaccines Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Sheep and Goat Pox Vaccines Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Sheep and Goat Pox Vaccines Revenue Market Share by Region (2017-2028)
Figure 55. China Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Sheep and Goat Pox Vaccines Sales Market Share by Type (2017-2028)
Figure 62. South America Sheep and Goat Pox Vaccines Sales Market Share by Application (2017-2028)
Figure 63. South America Sheep and Goat Pox Vaccines Sales Market Share by Country (2017-2028)
Figure 64. South America Sheep and Goat Pox Vaccines Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Sheep and Goat Pox Vaccines Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Sheep and Goat Pox Vaccines Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Sheep and Goat Pox Vaccines Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Sheep and Goat Pox Vaccines Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Sheep and Goat Pox Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Sheep and Goat Pox Vaccines in 2021
Figure 76. Manufacturing Process Analysis of Sheep and Goat Pox Vaccines
Figure 77. Sheep and Goat Pox Vaccines Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source